Regulation of cellular apoptosis using modulators of...

Details Regulation of cellular apoptosis using modulators of... Regulation of cellular apoptosis using modulators of...

A - Human Necessities

61

K

A61K 31/00 (2006.01) A61K 31/135 (2006.01) A61K 31/165 (2006.01) A61K 31/195 (2006.01) A61K 31/36 (2006.01) A61K 31/415 (2006.01) A61K 31/47 (2006.01) A61K 31/535 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2304843

The invention concerns the use of .beta.2-adrenergic modulators for regulating cellular apoptosis (agonists such as clenbuterol, salbutamol, procaterol or isoproterenol or antagonists such as propanolol, ICI 118, 551 or butoxamine) to modulate cellular apoptosis, more particularly hepatic cellular apoptosis.

L'invention est relative à l'utilisation de modulateurs .beta.2-adrénergiques (agonistes tels que le clenbutérol, le salbutamol, le procatérol or l'isoprotérénol ou antagonistes tels que le propranolol, le ICI 118, 551 ou la butoxamine) pour moduler l'apoptose cellulaire, plus particulaire hépatique.

Affiliated with

Also associated with

Rating

Regulation of cellular apoptosis using modulators of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Regulation of cellular apoptosis using modulators of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of cellular apoptosis using modulators of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1993549